1. Home
  2. INBS vs OGEN Comparison

INBS vs OGEN Comparison

Compare INBS & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBS
  • OGEN
  • Stock Information
  • Founded
  • INBS 2016
  • OGEN 1996
  • Country
  • INBS United States
  • OGEN United States
  • Employees
  • INBS N/A
  • OGEN N/A
  • Industry
  • INBS Medical Specialities
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • INBS Health Care
  • OGEN Health Care
  • Exchange
  • INBS Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • INBS 6.4M
  • OGEN 5.4M
  • IPO Year
  • INBS N/A
  • OGEN N/A
  • Fundamental
  • Price
  • INBS $0.69
  • OGEN $0.92
  • Analyst Decision
  • INBS
  • OGEN
  • Analyst Count
  • INBS 0
  • OGEN 0
  • Target Price
  • INBS N/A
  • OGEN N/A
  • AVG Volume (30 Days)
  • INBS 265.2K
  • OGEN 49.9K
  • Earning Date
  • INBS 11-12-2025
  • OGEN 11-07-2025
  • Dividend Yield
  • INBS N/A
  • OGEN N/A
  • EPS Growth
  • INBS N/A
  • OGEN N/A
  • EPS
  • INBS N/A
  • OGEN N/A
  • Revenue
  • INBS $3,292,042.00
  • OGEN N/A
  • Revenue This Year
  • INBS $778.48
  • OGEN N/A
  • Revenue Next Year
  • INBS N/A
  • OGEN N/A
  • P/E Ratio
  • INBS N/A
  • OGEN N/A
  • Revenue Growth
  • INBS 3.26
  • OGEN N/A
  • 52 Week Low
  • INBS $0.64
  • OGEN $0.82
  • 52 Week High
  • INBS $2.75
  • OGEN $18.90
  • Technical
  • Relative Strength Index (RSI)
  • INBS 30.21
  • OGEN 30.30
  • Support Level
  • INBS $0.64
  • OGEN $0.82
  • Resistance Level
  • INBS $0.69
  • OGEN $1.22
  • Average True Range (ATR)
  • INBS 0.05
  • OGEN 0.07
  • MACD
  • INBS 0.00
  • OGEN -0.02
  • Stochastic Oscillator
  • INBS 17.04
  • OGEN 29.97

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: